PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-3473

  1. 4,523 Posts.
    lightbulb Created with Sketch. 110
    From equity investment perspective, PAR is defensive, the demand side does not soften with a soft economy. PAR is growth, the base of our target market steadily increases regardless. Currently at the macro level our share price (and many others) is suffering from a shrinking global balance sheet ie the total money pool is not growing (???), and micro-wise PAR is still hugely under appreciated, an inefficient stock market if you like. And socially investor appetite for risk is very low.

    None of the above negates the huge potential value in PAR though.

    Are we destined to lose our shirt from misplacing our confidence in PAR?
    Are we on our way to financially freedom for our sound judgement on PAR?

    Last edited by hercules007: 04/01/23
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
0.035(12.7%)
Mkt cap ! $108.4M
Open High Low Value Volume
27.5¢ 31.0¢ 27.5¢ $108.9K 371.2K

Buyers (Bids)

No. Vol. Price($)
1 1000 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 17420 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.